Hsp90 is expressed and represents a therapeutic target in human oesophageal cancer using the inhibitor 17-allylamino-17-demethoxygeldanamycin

por Wu, X, Wanders, A, Wardega, P, Tinge, B, Gedda, L, Bergstrom, S, Sooman, L, Gullbo, J, Bergqvist, M, Hesselius, P, Lennartsson, J, Ekman, S
Publicado 2009

A short isoform of ATG7 fails to lipidate LC3/GABARAP

por Ogmundsdottir, M. H., Fock, V., Sooman, L., Pogenberg, V., Dilshat, R., Bindesbøll, C., Ogmundsdottir, H. M., Simonsen, A., Wilmanns, M., Steingrimsson, E.
Publicado 2018

Publisher Correction: A short isoform of ATG7 fails to lipidate LC3/GABARAP

por Ogmundsdottir, M. H., Fock, V., Sooman, L., Pogenberg, V., Dilshat, R., Bindesbøll, C., Ogmundsdottir, H. M., Simonsen, A., Wilmanns, M., Steingrimsson, E.
Publicado 2018